An open label, randomized control study for the comparison of effectiveness between Alfa-Glucosidase inhibitor and Dipeptidyl peptidase-4 (DPP-4) inhibitor in people with type 2 diabetes treated diet therapy and/or single oral hypoglycemic agent
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000003503
- Lead Sponsor
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 260
Inclusion Criteria
Not provided
Exclusion Criteria
1.None Type 2 diabetes 2.Medical history and/or complication of diabetic ketoacidosis 3.Medical history and/or complication of severe hypoglycemia 4.Insulin treatment within 16 weeks prior to the study 5.Treatment with Alfa-glucosidase inhibitors or sitagliptin within 12 weeks prior to the study 6.Treatment with glucocorticoid 7.Unstable glycemic contol 8.Hypersensitivity to or contraindication of sitagliptin and voglibose 9.AST or ALT >=2.5 time of institutional upper normal limit 10.Uncontrolled hypertension(systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg) 11.Severe health problems not suitable for the study 12.Pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1C
- Secondary Outcome Measures
Name Time Method